Skeletal Muscle Index and a Neuromuscular Blocking Agent
ConditionNeuromuscular Blockade
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19-80
SponsorSeoul National University Bundang Hospital
About this trial
With the recent development of image analysis, it has become possible to measure the skeletal muscle index representing the subject's muscle mass from preoperative computed tomography (CT) images. Therefore, in this study, the investigators quantify the skeletal muscle index from preoperative CT images and analyze the correlation with the dose of neuromuscular blocking agent, rocuronium, required for maintaining deep neuromuscular blockade.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Those who voluntarily agreed and signed the written consent form before participating in the study
American Society of Anesthesiologists physical class (ASA class) 1-3
Patients scheduled for elective colon surgery under general anesthesia
Patients undergoing abdominal computed tomography for routine preoperative preparation
Disqualifiers
Pregnant women
Decreased renal function (GFR<60mL/min/1.73m2).
Patients taking drugs that affect deep neuromuscular blockade
Patients with a history of neuromuscular and muscle disorders
Trial population
Patients scheduled for elective colon surgery under general anesthesia
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Skeletal Muscle index
Muscle amount
Time frame
preoperative periodLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: